Skip To Main Content
Xiyidan Aimaiti on Muck Rack

Xiyidan Aimaiti

As seen in: Nature, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xiyidan

Contact Xiyidan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Multi-cancer profiling and breast cancer validation reveal YME1L1 as a potential immune-related factor and prognostic biomarker

|
By Xiyidan Aimaiti, Yiyang Wang, Jiawei Zhao, Yongxiang Li, Haotian Ma, Tong Wu, Dilimulati Ismtula, Chenming Guo, Zhexi Ji
| Nature Verified
Abstract Mitochondrial dysfunction constitutes a fundamental driver of neoplastic transformation. YME1L1, an inner mitochondrial membrane-resident AAA+ metalloprotease, is associated with protein homeostasis in the inner mitochondrial membrane and intermembrane space, thus participating in cellular metabolic reprogramming. Nevertheless, systematic interrogation of YME1L1 across Multiple cancers remains conspicuously absent.
Open in Who Shared Issue with article?

Bystin Is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis t

|
By Yiyang Wang, Yongxiang Li, Xiyidan Aimaiti, Dilimulati Ismtula
| Dove Medical Press
Back to Journals » Breast Cancer: Targets and Therapy » Volume 17 Authors Aimaiti X, Wang Y, Ismtula D, Li Y , Ma H, Wang J, Elihamu D, Guo C Received 11 June 2025 Accepted for publication 20 August 2025 Published 29 August 2025 Volume 2025:17 Pages 755—779 DOI https://doi.org/10.2147/BCTT.S537429 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Robert Clarke Xiyidan Aimaiti,1,2,* Yiyang Wang,1,2,*...
Open in Who Shared Issue with article?
See all 2 articles